Services
Listings
-
MINO
Data Management Shirley (New York) September 30, 2026 1.00 Dollar US$Established from peripheral blood mononuclear cells of a 68-year-old white woman with mantle cell lymphoma at relapse in 1997; described to carry a t(11;14)(q13;q32) leading to CCND1-IGH@ (BCL1-IGH) fusion gene https://www.creative-bioarray.com/MINO-...
-
Minipig Cardiomyocytes
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Minipig cardiomyocytes from Creative Bioarray are isolated from the minipig heart tisse. The method we use to isolate minipig cardiomyocytes was developed based on a combination of established and our proprietary methods. The minipig cardiomyocytes a...
-
MIN6
Immunology Shirley (USA) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9215W Description MIN6 cells excreted insulin, glucagon, somatostatin and ghrelin. Species Mus musculus (Mouse) Source Pancreas https://www.creative-bioarray.com/MIN6-CSC-C9215W-item-42148.htm
-
Beta-TC-6
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9159W Description The cell line was derived from a pancreatic tumor (insulinoma) arising in a transgenic mouse. Species Mus musculus (Mouse) Source Pancreas https://www.creative-bioarray.com/Beta-TC-6-CSC-C9159W-item-42092.htm
-
ATDC5
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6480J Description Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived. Species Mus musculus (Mouse) https://www.creative-bioarray.com/atdc5-item-csc-c6480j-43080.htm
-
ECPC-3
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6391J Description Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Species Mus musculus (Mouse) Source Brain https://www.creative-bioarray.com/ecpc-3-item-csc-c6391j-42991.htm
-
ECPC-4
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6392J Description Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Species Mus musculus (Mouse) Source Brain https://www.creative-bioarray.com/ecpc-4-item-csc-c6392j-42992.htm
-
LM8
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6376J Description A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin). Species Mus musculus (Mouse) Source Bone https://www.creative-bioarray.com/lm8-item-csc-c6376j-42976.htm
-
MB-03
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established from the larvae of the butterfly Mamestra brassicae (family Noctuidae, subfamily Noctuinae) (cabbage moth; Kohleule) https://www.creative-bioarray.com/MB-03-CSC-C6203X-item-1683.htm
-
MBT-2
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6483J Description Murine transitional cell carcinoma induced by FANFT. Species Mus musculus (Mouse) Source Bladder Metastasis https://www.creative-bioarray.com/mbt-2-item-csc-c6483j-43083.htm
-
Immortalized Mouse Microglia (BV2)
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Immortalized Mouse Microglial (BV2) cells have become a popular substitute for primary microglia in many experiments. These cells were derived from C57/BL6 neonatal microglia and immortalized using the v-raf/v-myc-carrying J2 retrovirus. BV2 cells ex...
-
GL261
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established as in vitro growing cell culture in the mid 1990s from the Gl261 tumor which was induced in 1939 by intracranial injection of 3-methylcholanthrene into C57BL/6 mice and subsequently maintained by serial transplantation in syngeneic mouse ...











